Consortium announced the launch of its official website, creating a central hub for information about its initiatives and clinical research studies. ALL-ALS.org is designed to inform and engage ...

For the millions of people worldwide who have lost their ability to speak due to stroke, ALS, or other neurological injuries, a revolutionary technology is breaking down barriers to communication.

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune ...

As Oklahoma lawmakers consider House Bill 1278, which aims to fund research and care for those battling Amyotrophic Lateral Sclerosis (ALS), Michael Wilson and his family share firsthand their ...

Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a study published in Neuron, ...

NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...

Columnist Kristin Neva writes that, with her husband's ALS, it feels like they're living in the middle of a long story with no resolution.